 |
|
Praxis Launches Patient Recruitment Campaign for Investigational Inhaled Insulin
for a Type 2 Diabetes Study
Brentwood, TN -- Nov. 2, 2005 -- Praxis,
a company specializing in centralized patient recruitment
for clinical research studies, is providing services to a
major pharmaceutical company for a medical research study
taking place in 18 cities across the United States. The recruitment
period will last six months for this Phase III b study, which
will study an investigational inhaled insulin for type 2
diabetes.
Praxis is providing a variety of services for the medical
research study, including patient education materials, website
development, print advertising, direct marketing, community
outreach, public relations, and retention program management.
"This study continues our relationship with a longstanding
client," said David Fox, president and CEO of Praxis. "Our
strategic approach will help them meet their recruitment
goals on schedule and hopefully help to bring to market a
medication that could help millions of people with diabetes
."
Praxis Communications, Inc., headquartered
in Brentwood, TN, provides the pharmaceutical and biotech
industries with a wide range of services for patient recruitment
and retention for clinical trials including patient profiling,
recruitment planning, centralized fulfillment, media relations,
advertising, and program management. For more information,
call Praxis at (615) 312-8207.
> Back to Press Release archive
|
|
|
